GleamWall
中文EN

CVS CVS HEALTH Corp

Retail-Drug Stores and Proprietary Stores · NYSE · SEC CIK 64803 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY2,253.3%
TTM EPS YoY2,165.8%
Revenue 3-yr CAGR6.5%
Net income 3-yr CAGR8.5%

Margins

Gross margin44.2%
Operating margin3.6%
Net margin2.6%
FCF margin3.7%
EBITDA margin4.7%

Returns

ROE14.4%
ROA4.3%
ROIC (approx.)10.8%
Asset turnover1.64x

Leverage & solvency

Liabilities / assets68.7%
Debt / equity0.75x
Current ratio0.85x
Interest coverage4.91x

Cash quality & payout

Operating cash flow / net income1.70x
Accruals ratio-3.0%
Payout ratio31.0%
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$108.40B$106.10B$100.43B$105.69B$102.87B$98.92B$94.59B$97.71B
Cost of revenue$61.19B$58.86B$55.44B$59.06B$57.05B$54.01B$51.06B$55.27B
Gross profit$47.21B$47.23B$44.98B$46.63B$45.83B$44.91B$43.53B$42.44B
Operating income$3.57B$4.70B$4.68B$2.11B-$3.21B$2.38B$3.37B$2.37B
Interest expense$747.00M$757.00M$774.00M$787.00M$784.00M$763.00M$785.00M$758.00M
Pretax income$2.85B$3.98B$3.94B$1.35B-$3.48B$1.65B$2.62B$2.13B
Income tax$678.00M$982.00M$981.00M-$1.57B$508.00M$634.00M$835.00M$503.00M
Net income$2.17B$2.98B$2.94B$2.94B-$3.98B$1.02B$1.78B$1.64B
EBITDA$4.70B$5.83B$5.79B$3.26B-$2.07B$3.55B$4.53B$3.52B
EPS (basic)1.702.332.31—-3.130.811.41—
EPS (diluted)1.682.312.30—-3.130.801.41—
Dividends declared per share0.670.670.670.670.670.670.670.67
Weighted avg. shares (diluted)1.29B1.29B1.28B—1.27B1.27B1.26B—
Balance sheet
Cash & equivalents$11.74B$11.33B$9.54B$8.45B$9.35B$12.03B$10.35B$8.88B
Short-term investments$3.15B$2.63B$2.26B$2.15B$2.13B$2.39B$2.58B$2.41B
Receivables$42.07B$40.31B$40.99B$39.78B$43.86B$40.65B$39.62B$36.47B
Inventory$18.24B$17.62B$17.77B$19.25B$18.96B$17.45B$17.39B$18.11B
Current assets$79.39B$75.35B$74.82B$74.71B$77.11B$75.65B$73.19B$68.64B
PP&E, net$13.32B$13.17B$13.04B$13.08B$12.84B$12.82B$12.86B$12.99B
Goodwill$85.48B$85.48B$85.48B$85.48B$85.48B$91.20B$91.20B$91.27B
Intangibles$24.22B$24.64B$25.07B$25.51B$25.98B$26.22B$26.57B$27.32B
Total assets$258.07B$253.77B$252.97B$253.54B$255.33B$258.34B$255.59B$253.22B
Current liabilities$93.10B$87.04B$86.41B$88.69B$92.69B$94.16B$88.96B$84.61B
Short-term debt$3.46B$1.96B$2.58B$4.07B$1.25B$3.04B$1.26B$2.12B
Long-term debt$57.22B$59.45B$60.53B$60.50B$60.51B$57.29B$59.04B$60.53B
Total debt$60.68B$61.41B$63.11B$64.57B$61.76B$60.33B$60.30B$62.65B
Total liabilities$177.39B$173.87B$175.34B$178.16B$182.22B$180.79B$178.47B$177.49B
Shareholders' equity$80.50B$79.70B$77.46B$75.21B$72.93B$77.38B$76.93B$75.56B
Net debt$48.94B$50.08B$53.57B$56.12B$52.40B$48.30B$49.95B$53.76B
Shares outstanding1.28B1.28B1.27B1.27B1.27B1.27B1.26B1.26B
Cash flow statement
Operating cash flow$4.72B$6.34B$4.25B$3.39B$796.00M$1.90B$4.56B$1.86B
Capital expenditure$817.00M$691.00M$849.00M$784.00M$698.00M$607.00M$743.00M$768.00M
Free cash flow$3.91B$5.65B$3.40B$2.61B$98.00M$1.29B$3.81B$1.09B
Investing cash flow-$2.79B-$1.88B-$874.00M-$2.00B-$2.09B-$1.02B-$762.00M-$547.00M
Financing cash flow-$1.53B-$2.69B-$2.32B-$2.03B-$1.38B$806.00M-$2.33B$431.00M
Depreciation & amortization$1.13B$1.13B$1.11B$1.15B$1.13B$1.17B$1.15B$1.15B
Stock-based compensation$168.00M$176.00M$266.00M$135.00M$138.00M$136.00M$126.00M$137.00M
Dividends paid$853.00M$878.00M$847.00M$845.00M$846.00M$866.00M$840.00M$838.00M
Share buybacks———$0$0$0$0$0

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.